Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110649 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Damir Garcia-Cehic und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA. Hauptthemen laut MEDLINE: Hepacivirus, Drug Resistance, Viral, Antiviral Agents, Hepatitis C, Chronic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre for Industrial Technological Development, Spanish Ministry of Economy and Business, Spanish Ministry of Education.
Abstract (Originalsprache)
Egypt has the highest global prevalence of hepatitis C virus (HCV), with genotype 4 (G4) in over 94% of cases. Direct-acting antivirals (DAAs) yield sustained virologic response (SVR) rates above 95%. Second-generation DAAs are recommended for patients with virological failure, achieving over 90% eradication. This study aimed to classify and evaluate the pattern of HCV resistance-associated substitutions (RASs) in patients who failed DAA treatment in Egypt. A total of 1778 chronically infected HCV patients from Egypt’s Nile Delta were enrolled (2016–2018). Among them, 37 relapsed, and high-quality serum samples from 22 patients were available, including 6 cases with pre- and post-treatment samples. Next-generation sequencing (NGS) was performed for HCV subtyping and RAS identification. Among the 22 analyzed cases, 21 (95.4%) were G4: 11 were classified as subtype G4a, seven G4o, and three G4m. One patient (4.5%) was identified as G1g. One case shifted from G4a pre- to G4o post-treatment, suggesting reinfection. The RAS pattern in rare G4 subtypes (G4m/G4o) differs from the G4a subtype. The combination of L28M/L30S mutations was detected in 8/11 G4a samples; in contrast, RASs in G4o were characterized by T30S or Y93C/H/N/S substitutions. Notably, some substitutions identified as RASs may represent fixed polymorphisms in regional viral populations, such as those in Egypt’s Nile Delta. HCV subtypes significantly influence the RAS pattern, particularly within the NS5A region, after DAA-treatment failure. The RAS pattern differs among G4 subtypes, particularly in rare ones, predisposing patients to resistance and underscoring the importance of NGS in regional populations to optimize treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA.
- Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Pathology, National Liver Institute, Menoufia University, Menoufia Governorate 6131567, Egypt.
- Sustainable Sciences Institute Collaborative Research Center, Menoufia University, Menoufia Governorate 6131567, Egypt.
- Molecular Diagnostic Unit, New Kasr El-Ainy Teaching Hospital, Cairo University, Giza Governorate 12613, Egypt.
ORCID-Profile: Damir Garcia-Cehic, Heba A Gad, Asmaa Ibrahim Gomaa, Marta Ibañez Lligoña, Josep Gregori, Carolina Campos, Francisco Rodriguez-Frias, Mohamed Helmy Abdel-Rahman, Josep Quer
Förderung
- Centre for Industrial Technological Development
- Spanish Ministry of Economy and Business
- Spanish Ministry of Education
- La Caixa" Foundation
- Gilead Corporate
- Gilead
- Centro para el Desarrollo Tecnológico Industrial
- Instituto de Salud Carlos III
Zitieren
APA
Garcia-Cehic, D., Mosbeh, A., A Gad, H., Gomaa, A. I., Ibañez Lligoña, M., Gregori, J., Colomer-Castell, S., Campos, C., Rodriguez-Frias, F., Esteban, J. I., Kohla, M. S., Abdel-Rahman, M. H., & Quer, J. (2025). Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110649
Vancouver
Garcia-Cehic D, Mosbeh A, A Gad H, Gomaa AI, Ibañez Lligoña M, Gregori J, et al. Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110649
BibTeX
@article{GarciaCehic2025,
author = {Garcia-Cehic, Damir and Mosbeh, Asmaa and A Gad, Heba and Gomaa, Asmaa Ibrahim and Ibañez Lligoña, Marta and Gregori, Josep and Colomer-Castell, Sergi and Campos, Carolina and Rodriguez-Frias, Francisco and Esteban, Juan Ignacio and Kohla, Mohamed S and Abdel-Rahman, Mohamed Helmy and Quer, Josep},
title = {Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110649}
}
EUVIMED